Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
The American Journal of Cardiology|December 8, 2009
Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapyGregory A Nichols, Baishali M Ambegaonkar, Vasilisa Sazonov, et al.The American Journal of Managed Care|November 20, 2002
Understanding changes in primary care clinicians' satisfaction from depression care activities during adoption of selective serotonin reuptake inhibitorsDiana Shye, Jonathan B Brown, John P Mullooly, et al.Diabetes Care|July 28, 2004
The incidence of congestive heart failure in type 2 diabetes: an updateGregory A Nichols, Christina M Gullion, Carol E Koro, et al.Diabetes/Metabolism Research and Reviews|September 24, 2004
The incidence of congestive heart failure associated with antidiabetic therapiesGregory A Nichols, Carol E Koro, Christina M Gullion, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Contemporary analysis of secondary failure of successful sulfonylurea therapyGregory A Nichols, Charles M Alexander, Cynthia J Girman, et al.Archives of Internal Medicine|February 13, 2002
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular diseaseJonathan B Brown, Thomas E Delea, Gregory A Nichols, et al.Diabetes Care|March 1, 2006
Treatment escalation and rise in HbA1c following successful initial metformin therapyGregory A Nichols, Charles M Alexander, Cynthia J Girman, et al.Current Medical Research and Opinion|November 7, 2009
Successes and challenges of insulin therapy for type 2 diabetes in a managed-care settingGregory A Nichols, Shravanthi R Gandra, Chiun-Fang Chiou, et al.International Journal of Public Health|September 6, 2014
Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of ArgentinaJorge F Elgart, Santiago Asteazarán, Jorge L De La Fuente, et al.Pharmacogenomics|April 27, 2010
Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotypeShany Blum, Moshe Vardi, Jonathan B Brown, et al.Pageof 3